Literature DB >> 3232997

Heaf test results after neonatal BCG.

P A Crawshaw1, A H Thomson.   

Abstract

Heaf testing was carried out on 98 preschool Asian children who had received a BCG vaccination. A strongly positive Heaf reaction (grade 3) occurred in only two children. Heaf testing can still be used in tuberculosis screening after neonatal BCG.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3232997      PMCID： PMC1779186          DOI： 10.1136/adc.63.12.1490

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Sensitivity of neonates to tuberculin after BCG vaccination.

Authors:  J W Hadfield; J Allan; W J Windebank
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

2.  Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.

Authors:  L P Ormerod
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

3.  Tuberculin response two years after BCG vaccination at birth.

Authors:  H Grindulis; M I Baynham; P H Scott; R A Thompson; B A Wharton
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

4.  Tuberculin reactivity in a chest clinic: the effects of age and prior BCG vaccination.

Authors:  S Capewell; A G Leitch
Journal:  Br J Dis Chest       Date:  1986-01
  4 in total
  4 in total

1.  BCG vaccination in children.

Authors: 
Journal:  BMJ       Date:  1990-12-01

2.  Tuberculin skin reactivity four years after neonatal BCG vaccination.

Authors:  L P Ormerod; J M Garnett
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 3.  Neonatal BCG immunisation.

Authors:  A Clarke; P Rudd
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

4.  Use of the 1 tuberculin unit (TU) Mantoux test in the assessment of tuberculous infection in children following neonatal BCG vaccination.

Authors:  E W Hoskyns; H Simpson; P Monk
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.